Home » Investors » Press Releases

Press Releases

Date Title
Dec 21, 2020 DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
Dec 21, 2020 Results of Annual General Meeting of Shareholders Held December 17, 2020
Dec 23, 2019 Parnell Pharmaceuticals Holdings Ltd Announces Business Update
Oct 14, 2019 Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update
Jun 7, 2019 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019
Apr 30, 2019 Notice of Annual General Meeting and Explanatory Memorandum
Apr 5, 2019 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance
Nov 2, 2018 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Aug 3, 2018 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018
Jul 31, 2018 Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management
Jun 5, 2018 Results of Annual General Meeting of Shareholders Held May 31, 2018
Apr 30, 2018 Notice of Annual General Meeting and Explanatory Memorandum
Apr 27, 2018 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended March 31, 2018 and Reports 2017 Full Year Financial Results
Feb 22, 2018 Results of General Meeting of Shareholders Held February 22, 2018
Jan 11, 2018 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Nine Months Ended September 30, 2017; Board and Senior Management Changes; Strategic Review of Development Pipeline Including Zydax Canine and 2018 Guidance
Jan 11, 2018 Notice of General Meeting and Explanatory Memorandum
Jan 4, 2018 Parnell Appoints Tony G Hartnell AM to Board of Directors
Jan 3, 2018 Results of General Meeting of Shareholders held December 29, 2017
Nov 21, 2017 Notice of Annual General Meeting and Explanatory Memorandum
Aug 17, 2017 Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017
May 24, 2017 Parnell Pharmaceuticals Holdings Ltd Announces Business Results Update
May 18, 2017 Parnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017
Apr 28, 2017 Notice of Annual General Meeting and Explanatory Memorandum
Mar 21, 2017 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2016
Feb 27, 2017 UPDATED:  Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017
Feb 23, 2017 Parnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017
Dec 19, 2016 Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ
Dec 9, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market
Dec 9, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market
Nov 22, 2016 Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility
Nov 2, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016
Oct 27, 2016 Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016
Aug 4, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016
Jul 26, 2016 Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016
Jul 26, 2016 Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016
May 31, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial
May 12, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock
Apr 22, 2016 Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update
Apr 18, 2016 Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016
Mar 31, 2016 Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit
Feb 24, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015
Feb 18, 2016 Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016
Jan 20, 2016 UPDATE — Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares
Jan 19, 2016 Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Captial Fund to Purchase Ordinary Shares
Jan 11, 2016 Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference in San Francisco
Dec 17, 2015 Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors
Dec 17, 2015 Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors
Nov 18, 2015 Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Global Healthcare Conference in London
Oct 21, 2015 Parnell Pharmaceuticals Holdings Ltd Announces Third Quarter Business Results
Oct 9, 2015 Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015
Oct 9, 2015 Parnell Pharmaceuticals Holdings Ltd Restructures Board
Sep 28, 2015 Parnell Pharmaceuticals Holdings Ltd to Present at Ladenburg Thalmann 2015 Healthcare Conference
Aug 11, 2015 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2015
Aug 10, 2015 Parnell Appoints Peter A. Croden to Board of Directors
Jul 29, 2015 Parnell to Report Financial Results for the Six Months Ended June 30, 2015 on August 11, 2015
Jun 18, 2015 Parnell Pharmaceuticals Holdings Ltd Investor Day Highlights
Jun 18, 2015 Parnell Pharmaceuticals Holdings Ltd Announces $11 Million Secured Term Loan Facility
Jun 18, 2015 Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax(R), Disease-Modifying Osteoarthritis Drug in Dogs
Jun 8, 2015 Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences
May 20, 2015 Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Healthcare Conference
Apr 22, 2015 Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results
Apr 13, 2015 Parnell to Discuss First Quarter Business Performance on April 22, 2015
Mar 9, 2015 Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit
Feb 25, 2015 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014
Jan 12, 2015 Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference
Dec 19, 2014 Parnell Management Adopts 10b5-1 Trading Plans
Dec 9, 2014 Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility
Dec 9, 2014 Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End
Nov 12, 2014 Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences
Sep 15, 2014 Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results
Sep 10, 2014 Parnell to Report Fiscal Year 2014 Financial Results September 15, 2014
Sep 8, 2014 Parnell Appoints US-Based Independent Directors Phyllis Gardner, M.D., and David L. Greenwood to Its Board of Directors
Sep 3, 2014 Parnell Announces Results From the Successful Efficacy Study for Zydax(R)
Jul 24, 2014 Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
Jun 18, 2014 Parnell Pharmaceuticals (NASDAQ: PARN) to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO
May 21, 2014 Parnell Pharmaceuticals Files Registration for Proposed Initial Public Offering
Feb 25, 2013 Parnell Launches Synchronization Pack™
Aug 1, 2009 Australian Veterinary Pharmaceuticals Company Opens World Class Manufacturing Facility
To
Top